Financial Performance - The total revenue for the year ending December 31, 2025, was HKD 762,337,000, compared to HKD 216,159,000 for the previous year, representing a significant increase[4] - The cost of sales for the same period was HKD 892,284,000, up from HKD 123,684,000, leading to a gross loss of HKD 129,947,000 compared to a gross profit of HKD 92,475,000 in the prior year[4] - Other income and gains amounted to HKD 254,827,000, a substantial increase from HKD 2,010,000 in the previous year[4] - The company reported a net loss of HKD 117,190,000 before tax, compared to a loss of HKD 231,684,000 in the previous year, indicating an improvement[4] - The net profit attributable to the owners of the company was HKD 53,109,000, a recovery from a loss of HKD 203,483,000 in the previous year[4] - Basic earnings per share for the year was HKD 3.46, compared to a loss per share of HKD 13.24 in the previous year, showing a positive turnaround[4] - The comprehensive income for the year was HKD 20,036,000, recovering from a comprehensive loss of HKD 232,075,000 in the previous year[5] - The total comprehensive income attributable to the owners of the company was HKD 30,471,000, compared to a loss of HKD 205,201,000 in the previous year, indicating a significant recovery[5] Asset and Liability Management - Total non-current assets decreased to HKD 1,024,877,000 from HKD 1,741,641,000, representing a decline of approximately 41.2% year-over-year[6] - Current assets increased to HKD 1,366,758,000 from HKD 1,337,198,000, showing a growth of about 2.2% year-over-year[6] - Total assets amounted to HKD 2,391,635,000, down from HKD 3,078,839,000, indicating a decrease of approximately 22.4% year-over-year[6] - The total current liabilities amount to HKD 1,755,322,000, an increase from HKD 896,047,000 in the previous year[7] - The total non-current liabilities are HKD 1,341,605,000, a decrease from HKD 1,462,922,000 last year[7] - The company has a total equity of HKD 76,872,000, slightly up from HKD 76,547,000 in the previous year[7] - The group’s total liabilities increased to HKD 1,104,437,000 in 2025 from HKD 893,043,000 in 2024, showing a rise in financial obligations[41] Cash Flow and Liquidity - Cash and cash equivalents increased significantly to HKD 144,910,000 from HKD 8,656,000, marking a substantial growth of approximately 1,577.5% year-over-year[6] - The group has cash and cash equivalents of only approximately HKD 144.9 million, indicating significant liquidity concerns[11] - The directors believe the group will have sufficient working capital to support its operations and meet financial obligations for at least the next 12 months[12] - The group has received a commitment from a major shareholder to provide financial support of up to HKD 200 million if needed[14] - The group is actively seeking additional financing sources to strengthen its capital structure and reduce overall financing costs[14] Operational Strategy - The company plans to focus on expanding its market presence and enhancing its product offerings in the upcoming fiscal year[3] - The group is accelerating the delivery of completed properties to buyers as part of its strategy to improve cash flow[14] - The group aims to optimize project management to expedite construction completion standards[62] - The group plans to adjust marketing strategies and enhance sales returns in response to policy changes and market cycles in 2026[78] - The group aims to reduce total debt systematically through project sales and asset disposals, improving the debt structure and mitigating financial risks[78] Development Projects - The group has three ongoing development projects, including the German City project in Zhuhai, the Fuyuan Junting project in Chengdu, and the Fuyuan Plaza project in Doumen[59] - The German City project has achieved sales amounting to 88.49% of its total saleable area as of December 31, 2025[60] - The Fuyuan Junting project has a total building area of approximately 120,500 square meters, with 84,425 square meters available for sale, achieving sales of about 100% and 90.86% for phases one and two respectively by December 31, 2025[61] - The Fuyuan Guangchang project has a total building area of approximately 197,391 square meters, with sales contracts amounting to about 63.04% of the total saleable area by December 31, 2025, with construction completion delayed to December 2027[62] - The Taishan project has a total building area of approximately 534,191 square meters, with 88% of the project sold to external parties by the end of the year[63] Corporate Governance - The company is committed to maintaining high standards of corporate governance and transparency[79] - Mr. Zeng Haobang was appointed as an independent non-executive director and chairman of the nomination committee, ensuring compliance with listing rules regarding independent directors[82] - The audit committee, consisting of three independent non-executive directors, has reviewed the consolidated financial statements for the year ending December 31, 2025[86] - The financial statements have been audited by Zhongzheng Tianheng Certified Public Accountants, confirming consistency with the group's financial data[87] - The annual report for the year ending December 31, 2025, will include relevant information as required by listing rules and will be published on the company's and the exchange's websites[88]

中國文旅農業集團有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司將於 二零二六年三月二十七日（ 星期五 ）舉行董事會會議，藉以（ 其中包括 ）考慮及批准 本公司及其附屬公司截至二零二五年十二月三十一日止之全年業績及其刊發，以 及考慮派發末期股息（ 如有 ）。 承董事會命 中國文旅農業集團有限公司 公司秘書 朱浩天 香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 China Cultural Tourism and Agriculture Group Limited 中 國 文 旅 農 業 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：542） 董事會會議召開日期 於本公佈日期，董事會由執行董事楊立君先生（ 主席 ）及譚嘉偉先生，非執行董事 黃玉麟先生及獨立非執行董事陳凱寧女士、徐煒婷女士及曾浩邦先生組成。 香港，二零二六年三月十六日 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國文旅農業集團有限公司 FF301 II. 已發行股份及/或庫存股份變動及足夠公眾持股量的確認 1. 股份分類 普通股 股份類別 不適用 於香港聯交所上市 (註1) 是 證券代號 (如上市) 00542 說明 已發行股份（不包括庫存股份）數目 庫存股份數目 已發行股份總數 上月底結存 1,530,930,808 6,500,800 1,537,431,608 增加 / 減少 (-) 本月底結存 1,530,930,808 6,500,800 1,537,431,608 足夠公眾持股量的確認(註4) 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00542 | 說明 | | | ...

Core Insights - The health industry is experiencing unprecedented growth opportunities due to factors such as an aging global population, the prevalence of chronic diseases, rising consumer awareness, and innovations in artificial intelligence (AI) and digital technology [1][2] - In China, the aging process and widespread application of digital technology are expanding the "silver economy" within the health market [1] - The company aims to develop health, digital medical, and wellness services in response to the national "Healthy China" strategy, focusing on a three-dimensional health service ecosystem that transitions health management from "disease treatment" to "prevention and maintenance" [1] Group 1 - The company has recently completed the acquisition of Zhongshan Yuanqi Smart Health Technology Co., Ltd. and formed a research and development team composed of professionals in data science and health management [1] - This team will focus on health data analysis and intelligent services, developing a one-stop health management platform for real-time monitoring of health data across all demographics and life stages [1] - The platform will leverage general artificial intelligence (AGI) technology to promote healthy lifestyles and concepts to users [1] Group 2 - The platform is planned to integrate dynamic vital sign monitoring, intelligent risk assessment, personalized health interventions, and medication reminders, with connections to medical institutions, wellness service providers, and home care scenarios [2] - The company plans to increase investment in general artificial intelligence and big data systems in the health sector over the next three years to continuously advance technology iteration and platform optimization [2] - Once operational, the platform is expected to significantly enhance the company's revenue annually and gradually establish a dual-driven profit model through technology output and service subscriptions [2]

Core Viewpoint - The health industry is experiencing unprecedented growth opportunities driven by factors such as an aging population, prevalence of chronic diseases, rising consumer awareness, and innovations in artificial intelligence (AI) and digital technology [1][2] Group 1: Market Trends - The aging process in China and the widespread application of digital technology are expanding the "silver economy" within the health market [1] - The company aims to align with the national "Healthy China" strategy by developing health, digital medical, and wellness services [1] Group 2: Business Strategy - The company is focusing on building a three-dimensional health service ecosystem based on AI technology, which includes "smart health devices + community health services + digital empowerment" [1] - The company has recently completed the acquisition of Zhongshan Yuanqi Smart Health Technology Co., Ltd. and formed a research and development team with expertise in data science and health management [1] Group 3: Platform Development - The planned health management platform will integrate dynamic vital sign monitoring, intelligent risk assessment, personalized health interventions, and medication reminders, with connections to medical institutions and home care scenarios [2] - The company plans to increase investment in general AI and big data systems in the health sector over the next three years to enhance technology iteration and platform optimization [2] Group 4: Financial Outlook - The platform is expected to significantly boost the company's revenue once operational, creating a dual-driven profit model through technology output and service subscriptions [2] - The company believes that developing health, digital medical, and wellness services will enrich its existing business structure and cultivate new profit growth points, ultimately creating long-term sustainable value for shareholders and investors [2]

Core Viewpoint - The health industry is experiencing unprecedented growth opportunities driven by factors such as an aging global population, the prevalence of chronic diseases, rising consumer awareness, and innovations in artificial intelligence (AI) and digital technology [1] Group 1: Industry Trends - The aging population and widespread application of digital technology in China are expanding the "silver economy" within the health market [1] - The company aims to align with the national "Healthy China" strategy by developing health, digital medical, and wellness services [1] Group 2: Company Initiatives - The company has completed the acquisition of Zhongshan Yuanqi Smart Health Technology Co., Ltd. and formed a research team of professionals in data science and health management [1] - The research team will focus on health data analysis and intelligent services, developing a one-stop health management platform for real-time monitoring of health data across all demographics and life stages [1] Group 3: Platform Development - The planned platform will integrate dynamic vital sign monitoring, intelligent risk assessment, personalized health interventions, and medication reminders, with connections to medical institutions and home care services [2] - The company plans to increase investment in general AI and big data systems in the health sector over the next three years, expecting significant revenue growth once the platform is operational [2]

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 China Cultural Tourism and Agriculture Group Limited 中 國 文 旅 農 業 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：542） 自願公告 業務更新 本公 告由中 國文 旅農業 集團有 限公司「本公司」， 連同其 附屬公 司統 稱「本集 團」） 自願作出，旨在向本公司股東（「股東」）及潛在投資者提供本集團最新業務發展之 更新。 一 、市場背景與戰略方向 隨 著 全 球 人 口 結 構 老 化 、 慢 性 疾 病 盛 行 、 消 費 意 識 提 升 ， 以 及 人 工 智 慧 (AI) 與數位科技的創新應用等因素，大健康產業正迎來前所未有的發展機遇。特 別是在中國，隨著老齡化進程加快及數字技術廣泛應用，以「銀髮經濟」為代 表的大健康市場持續擴大。為積極響應國家「 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國文旅農業集團有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00542 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.05 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.05 HKD | | 1,000,000,000 | 本月底法定/註冊股本總額： HKD ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 佈 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部 或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 根據本集團截至二零二五年十二月三十一日止年度（「二零二五財政年度」）的未經 審核綜合管理賬目之初步審閱以及本公司現有資料，直至本公佈日期，計劃及措 施的落實狀況如下： 負債減少 於二零二四年十二月三十一日，本集團錄得流動負債淨額約港幣418,000,000元。 於二零二五年落實計劃及措施後，本集團的財務狀況預計已顯著好轉，從二零二 四年十二月三十一日約港幣400,000,000元的巨額淨流動負債，轉變為二零二五年 十二月三十一日數億港元的顯著正淨流動資產。 中國文旅農業集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事（「董 事」）會（「董事會」）謹此提供有關本集團為減緩本集團的流動性壓力及解決本公司 核 數 師 就 持 續 經 營 不 發 表 意 見 一 事 落 實 的 計 劃 及 措 施（「計 劃 及 措 施」， 具 體 內 ...

Summary of Key Points Core Viewpoint - As of January 9, a total of 73 stocks reached their 52-week highs, with notable performances from Lingxiong Technology (02436), Delai Construction (01546), and Zhipu (02513) showing significant growth rates of 104.99%, 38.89%, and 22.22% respectively [1]. 52-Week Highs - Lingxiong Technology (02436) closed at 11.760, with a peak price of 15.600, achieving a high rate of 104.99% [1]. - Delai Construction (01546) closed at 0.161, reaching a maximum of 0.250, with a high rate of 38.89% [1]. - Zhipu (02513) had a closing price of 158.600 and a peak of 165.000, resulting in a high rate of 22.22% [1]. - Other notable stocks include Asia Pacific Satellite (01045) with a high rate of 20.64% and Rongda Technology (09881) at 12.87% [1]. 52-Week Lows - The stocks reaching their 52-week lows include Lishi International (00842) with a closing price of 0.850, marking a decline of 39.29% [2]. - Bokan Vision Cloud - B (02592) closed at 2.930, with a decrease of 16.90% [2]. - Lingzai Technology Finance (00093) reached a low of 0.485, reflecting a drop of 14.77% [2].